15: The Drug Pricing Middlemen Driving up Drug Costs
We Can Do This!
English - December 01, 2021 10:00 - 46 minutes - 42.9 MBPolitics News Government advocacy reid maki economic reform fascism workers rights womens rights sally greenberg john breyault child labor food policy Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Healthcare continues to be front and center in the national discourse, particularly in the midst of the pandemic. As Congress works on policy solutions to lower healthcare costs for consumers, we face an unfair disadvantage when it comes to what we’re paying at the pharmacy counter. Many consumers don’t know that this is largely due to middlemen companies called pharmacy benefit managers (PBMs).
Antonio Ciaccia, President of 3Axis Advisors and Chief Executive Officer of 46brooklyn Research, joins NCL’s Executive Director Sally Greenberg to talk about the role PBMs play in our drug pricing system and how they impact what consumers pay out-of-pocket for their medicines.
*Due to COVID-19 safety protocols, this episode was recorded remotely. Audio quality may not be consistent throughout.*